Search by Drug Name or NDC

    NDC 43857-0636-01 Lipotox 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 30; 30; 30; 8; 30; 30; 30; 30; 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h Details

    Lipotox 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 30; 30; 30; 8; 30; 30; 30; 30; 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h

    Lipotox is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by BioActive Nutritional, Inc.. The primary component is ACETIC ACID; ANHYDROUS TRISODIUM CITRATE; ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BENZOIC ACID; BENZYL ALCOHOL; BORIC ACID; CHLORINE; CHOLESTEROL; CORTICOTROPIN; CORTISONE ACETATE; ESTRADIOL; ESTRONE; EUGENOL; FORMALDEHYDE SOLUTION; ISOPROPYL .

    Product Information

    NDC 43857-0636
    Product ID 43857-0636_c6b2d570-cc46-41fc-97f8-2734223ad76e
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lipotox
    Proprietary Name Suffix n/a
    Non-Proprietary Name Squalene, Cholesterinum, Estradiol, Progesterone, Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Arsenicum Album, Lycopodium Clavatum, Nux
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route ORAL
    Active Ingredient Strength 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 30; 30; 30; 30; 30; 8; 30; 30; 30; 30; 30
    Active Ingredient Units [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [h
    Substance Name ACETIC ACID; ANHYDROUS TRISODIUM CITRATE; ARSENIC TRIOXIDE; ASPARTAME; BENZALKONIUM CHLORIDE; BENZOIC ACID; BENZYL ALCOHOL; BORIC ACID; CHLORINE; CHOLESTEROL; CORTICOTROPIN; CORTISONE ACETATE; ESTRADIOL; ESTRONE; EUGENOL; FORMALDEHYDE SOLUTION; ISOPROPYL
    Labeler Name BioActive Nutritional, Inc.
    Pharmaceutical Class Acidifying Activity [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC],
    DEA Schedule n/a
    Marketing Category UNAPPROVED HOMEOPATHIC
    Application Number n/a
    Listing Certified Through 2024-12-31

    Package

    NDC 43857-0636-01 (43857063601)

    NDC Package Code 43857-0636-1
    Billing NDC 43857063601
    Package 30 mL in 1 BOTTLE, DISPENSING (43857-0636-1)
    Marketing Start Date 2023-09-05
    NDC Exclude Flag N
    Pricing Information N/A
    << 43857-0635-01 43857-0637-01 >>

    Contents